Patel, Hitisha K.
Tao, Nianjun
Lee, Kyung-Min
Huerta, Mariela
Arlt, Heike
Mullarkey, Tara
Troy, Steven
Arteaga, Carlos L.
Bihani, Teeru
Funding for this research was provided by:
Radius Health
Article History
Received: 16 September 2019
Accepted: 15 November 2019
First Online: 18 December 2019
Ethics approval and consent to participate
: All study protocols were reviewed by Radius, approved by Institutional Animal Care and Use Committees (IACUC), and conducted in accordance with the US and International regulations for the protection of laboratory animals.
: N/A
: H Patel, N Tao, H Arlt, T Mullarkey, S Troy, and T Bihani are employees and shareholders of Radius Health, Inc. CL Arteaga has received research grants from Puma Biotechnology, Pfizer, Lilly, Bayer, Takeda, and Radius. He holds stock options in Provista and Y-TRAP and serves in an advisory role to Novartis, Merck, Lilly, Symphogen, Daiichi Sankyo, Radius, Taiho Oncology, H3Biomedicine, OrigiMed, Puma Biotechnology, and Sanofi. He is a member of the Scientific Advisory Board (SAB) of the Komen Foundation. All other authors declare that they have no competing interests.